A BILL 
To direct the Secretary of Health and Human Services to 
increase Federal efforts to prepare for and respond to 
public health emergencies with respect to the spread 
of infectious diseases, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Infectious Disease Epi-
4
demic and Pandemic Preparedness Act’’. 
5
22:33 Jul 28, 2020
H7531
2 
•HR 7531 IH
SEC. 2. INCREASED PREPARATION AND RESPONSE FOR IN-
1
FECTIOUS DISEASES. 
2
(a) NATIONAL MEDICAL COMMAND.—Title III of the 
3
Public Health Service Act (42 U.S.C. 241 et seq.) is 
4
amended by inserting after section 319M the following: 
5
‘‘SEC. 319N. NATIONAL MEDICAL COMMAND. 
6
‘‘(a) ESTABLISHMENT.—The Secretary, in consulta-
7
tion with the appropriate Federal agencies and depart-
8
ments, shall establish an interagency task force to be 
9
known as the National Medical Command to prepare for 
10
and respond to a public health emergency for which a dec-
11
laration is in effect under section 319 with respect to an 
12
infectious disease. 
13
‘‘(b) DUTIES.—The National Medical Command 
14
shall— 
15
‘‘(1) coordinate measures between Federal 
16
agencies to prevent and respond to a public health 
17
emergency described in subsection (a); 
18
‘‘(2) taking into consideration the coordinated 
19
strategy required under section 2802(a), develop a 
20
strategic plan to respond to a pandemic, including 
21
identifying strategies that may not be identified in 
22
such coordinated strategy; and 
23
‘‘(3) in coordination with the Director of the 
24
Centers for Disease Control and Prevention, develop 
25
a public health surveillance system with respect to 
26
22:33 Jul 28, 2020
H7531
3 
•HR 7531 IH
any infectious diseases that has a high mortality 
1
rate. 
2
‘‘(c) MEMBERSHIP.— 
3
‘‘(1) REPRESENTED OFFICES, AGENCIES, AND 
4
DEPARTMENTS.—The National Medical Command 
5
shall be composed of representatives of Federal 
6
agencies, offices, and departments, which shall in-
7
clude the following: 
8
‘‘(A) The Centers for Disease Control and 
9
Prevention. 
10
‘‘(B) The National Institute of Allergy and 
11
Infectious Diseases. 
12
‘‘(C) The Office of the Assistant Secretary 
13
for Preparedness and Response of the Depart-
14
ment of Health and Human Services. 
15
‘‘(D) The Office of Global Affairs of the 
16
Department of Health and Human Services. 
17
‘‘(E) The Occupational Safety and Health 
18
Administration. 
19
‘‘(F) The Federal Emergency Management 
20
Agency. 
21
‘‘(G) The Department of Defense. 
22
‘‘(H) The Department of Transportation. 
23
‘‘(I) The Department of State. 
24
22:33 Jul 28, 2020
H7531
4 
•HR 7531 IH
‘‘(J) The Environmental Protection Agen-
1
cy. 
2
‘‘(K) The National Security Council. 
3
‘‘(L) The Agency for International Devel-
4
opment. 
5
‘‘(M) The intelligence community. 
6
‘‘(2) 
REQUIREMENTS.—Each 
representative 
7
under paragraph (1) shall— 
8
‘‘(A) have appropriate technical expertise 
9
with respect to the duties of the National Med-
10
ical Command; and 
11
‘‘(B) be selected by the head of the agency, 
12
department, or office described in such para-
13
graph. 
14
‘‘(d) NATIONAL MEDICAL COMMANDER.—The Sec-
15
retary shall appoint a chair of the National Medical Com-
16
mand from among the members of the National Medical 
17
Command to be known as the Medical Commander for 
18
Pandemic Preparedness and Response (in this section re-
19
ferred to as the ‘Medical Commander’). 
20
‘‘(e) DURATION.—Notwithstanding section 14(a) of 
21
the Federal Advisory Committee Act, the National Medical 
22
Command shall continue in existence until otherwise pro-
23
vided by law.’’. 
24
22:33 Jul 28, 2020
H7531
5 
•HR 7531 IH
(b) EARLY DETECTION AND EARLY WARNING SYS-
1
TEMS MANAGEMENT.—Section 319D of the Public Health 
2
Service Act (247d–4) is amended— 
3
(1) in subsection (b), by inserting ‘‘, in coordi-
4
nation with the National Medical Command’’ after 
5
the first instance of ‘‘Secretary’’; and 
6
(2) in subsection (c), in paragraph (1), by strik-
7
ing ‘‘Secretary,’’ and inserting ‘‘Secretary, in coordi-
8
nation with the National Medical Command and’’. 
9
(c) ADMINISTRATION OVER NATIONAL STRATEGIC 
10
STOCKPILE.—Section 319F–2(a) of the Public Health 
11
Service Act (42 U.S.C. 247d–6b(a)) is amended— 
12
(1) in paragraph (1), by striking ‘‘Response’’ 
13
and inserting ‘‘Response, the Medical Commander 
14
for Pandemic Preparedness and Response,’’; and 
15
(2) in paragraph (2)— 
16
(A) in subparagraph (A)— 
17
(i) by striking ‘‘Secretary’’ and insert-
18
ing ‘‘Secretary, in collaboration with the 
19
Medical Commander for Pandemic Pre-
20
paredness and Response,’’; 
21
(ii) by striking ‘‘an annual’’ and in-
22
serting ‘‘a biannual’’; and 
23
(iii) by inserting ‘‘and September 15’’ 
24
after ‘‘March 15’’; and 
25
22:33 Jul 28, 2020
H7531
6 
•HR 7531 IH
(B) in subparagraph (B), by striking ‘‘an-
1
nual’’ and inserting ‘‘biannual’’. 
2
(d) STRATEGIC PLAN TO ADDRESS INFECTIOUS DIS-
3
EASES.— 
4
(1) STRATEGIC PLAN.— 
5
(A) IN GENERAL.—Not later than 1 year 
6
after the date of the enactment of this Act, the 
7
Director of the National Institutes of Health 
8
(in this section referred to as the ‘‘Director’’), 
9
in consultation with the Director of the Bio-
10
medical Advanced Research and Development 
11
Authority and the Commissioner of Food and 
12
Drugs, shall prepare and submit to Congress a 
13
strategic plan for fiscal years 2021 through 
14
2030 to identify, treat, and develop vaccines for 
15
infectious diseases. Such plan shall take into 
16
consideration, the coordinated strategy devel-
17
oped pursuant to section 2802(a) of the Public 
18
Health Service Act (42 U.S.C. 300hh–1(a)). 
19
(B) CONTENT.—The plan under subpara-
20
graph (A) shall address the following: 
21
(i) Research of pathogens, including 
22
research on the origins of zoonotic patho-
23
gens. 
24
22:33 Jul 28, 2020
H7531
7 
•HR 7531 IH
(ii) The development of cooperative 
1
partnerships to determine treatments and 
2
vaccines for COVID–19, and other similar 
3
infectious diseases. 
4
(iii) A strategy to fund clinical trials 
5
to determine which pathogens demonstrate 
6
a high mortality rate and high rate of in-
7
fection. 
8
(iv) The development of partnerships 
9
with private entities to allow such entities 
10
to eliminate industry risk. 
11
(2) EXPEDITED APPROVAL.—The Secretary of 
12
Health and Human Services, acting through the 
13
Commissioner of Food and Drugs, may designate a 
14
treatment or vaccine identified in the plan under 
15
this subsection as a breakthrough therapy, a fast 
16
track product, or eligible for accelerated approval as 
17
appropriate under section 506 of the Federal Food, 
18
Drug, and Cosmetic Act (21 U.S.C. 356). 
19
(3) AUTHORIZATION
OF
APPROPRIATIONS.— 
20
There are authorized to be appropriated to the Di-
21
rector to carry out this subsection $1,000,000,000 
22
for each fiscal year from 2021 through 2030. 
23
(e) COMMUNITY-BASED PREVENTION STRATEGIES 
24
GRANT PROGRAM.— 
25
22:33 Jul 28, 2020
H7531
8 
•HR 7531 IH
(1) IN GENERAL.—The Secretary of Health and 
1
Human Services shall award grants to community- 
2
based organizations for the purpose of preventing, 
3
identifying, tracking, and responding to infectious 
4
diseases, including reducing or eliminating health 
5
disparities with respect to race, gender, and socio-
6
economic status. 
7
(2) PRIORITY.—The Secretary may give priority 
8
to organizations that prioritize vulnerable popu-
9
lations and the treatment of individuals who are at 
10
a higher risk of mortality as a result of an infectious 
11
disease, including— 
12
(A) the elderly; 
13
(B) children; 
14
(C) the immunocompromised; 
15
(D) the homeless; and 
16
(E) individuals who have a low income. 
17
Æ 
22:33 Jul 28, 2020
H7531
